Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Grants Attract Top Researchers to Copenhagen

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
Two international leading researchers have each been awarded a Novo Nordisk Foundation Laureate Research Grant of DKK 40 million (€ 5.36 million).

The two professors will now move their research to University of Copenhagen. It is the first time the Foundation awards these new individual researcher grants.

The Danish research community will now be enriched by two of the world's leading names within cell regulation and bacterial persistence.

Professor Stephen M. Cohen, National University of Singapore, and Professor Kenn Gerdes, Newcastle University (UK), are the first to receive the Novo Nordisk Foundation's new Laureate Research Grants. The 7-year grants, which have been offered internationally in open competition, are of DKK 40 million (approx. € 5.36 million) each and are thus the largest individual research grants the Foundation has awarded to date. The aim of the grants is to bring international leading researchers within biomedicine and biotechnology to Denmark and thereby strengthen Danish research. The two professors will be employed at the University of Copenhagen and will be in Denmark for at least seven years.

"I am very pleased that Professor Stephen M. Cohen and Professor Kenn Gerdes choose to move their research to the University of Copenhagen. Their arrival means that the University will gain significant new research areas that may provide important contributions to the research at the Faculty of Health and Medical Sciences and the Faculty of Science," says Rector Ralf Hemmingsen, University of Copenhagen.

Genetic cooperation and bacterial life

Professor Stephen M. Cohen, 56 years of age, has amongst other scientific achievements during his career, made a major contribution to the understanding of how micro-RNA helps to control how a cell develops. Cohen's research in Denmark will focus primarily on the role that microRNA plays in relation to cancer. The research will help us to understand how different genes cooperate in the development of cancer and metastases. The ultimate goal is to identify new biomarkers for diagnostics and new targets for treatment.

Professor Kenn Gerdes, 58 years of age, has carried out pioneering research in persistence of bacterial infections. His research group has recently shown that the genetic elements known as toxin-antitoxin genes makes it possible for bacteria to stay alive in their host organism, even though they are sensitive to antibiotics. This can cause recurring or chronic infections. Gerdes' research in Denmark will focus on increasing our understanding of how bacteria survive and will promote the development of new methods for the control of relapsing and chronic infections.

Stephen M. Cohen and Kenn Gerdes will now start building their research groups at the University and will over the next few years gradually move all their operations to Copenhagen, so that in 2015 they will be fully employed at the University of Copenhagen.

"With the new, substantial Laureate Research Grants, the Novo Nordisk Foundation aims to bring some of the world's best researchers to Denmark. This will strengthen Danish research in both the short and long view, while also contributing to the Foundation’s vision of making Denmark an international beacon for research within biomedicine and biotechnology. This will be achieved by developing and strengthening the country's scientific skills, training researchers and achieving world class scientific results," says chairman of the Board of the Novo Nordisk Foundation, Ulf. J. Johansson.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Discovery Accelerates Targeted Cancer Treatment
In collaboration with international scientists, researchers from the University of Copenhagen have developed a method to help shorten the road to better cancer treatment.
Monday, May 11, 2015
Protein Paves the Way for Correct Stem Cell Differentiation
Research from BRIC, University of Copenhagen, has identified a crucial role of the molecule Fbxl10 in differentiation of embryonic stem cells.
Monday, February 11, 2013
Reconsidering Cancer's Bad Guy
Researchers at the University of Copenhagen have found that a protein, known for causing cancer cells to spread around the body, is also one of the molecules that trigger repair processes in the brain.
Tuesday, November 20, 2012
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Pumpjack" Mechanism for Splitting and Copying DNA
High-resolution structural details of cells' DNA-replicating proteins offer new insight into how these molecular machines function
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!